Minnesota HF4412 modifies medical cannabis endorsement requirements, including consultation and distribution rules.
Minnesota HF4412 amends the state's medical cannabis endorsement requirements. It specifies that only licensed pharmacists or certified medical cannabis consultants can authorize the distribution of medical cannabis flower and cannabinoid products. These professionals must consult with patients to determine the appropriate type, product, dosage, and paraphernalia. The bill also mandates that cannabis businesses verify product safety and potency before distribution.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.